Prostaglandins differentially affect osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells

Tissue Engineering

Volumn 13, Issue 10, 2007, Pages 2495-2503

  Knippenberg, M ^a,b   Helder, M N ^b   De Blieck Hogervorst, J M A ^a   Wuisman, P I J M ^b   Klein Nulend, J ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENZYME ACTIVITY; ENZYME INHIBITION; TISSUE ENGINEERING; TRANSCRIPTION;

BONE FORMATION; MESENCHYMAL STEM CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOPROGENITORS;

CELLS;

ALKALINE PHOSPHATASE; CYCLOOXYGENASE 2; OSTEOPONTIN; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR RUNX2;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TISSUE ENGINEERING; UPREGULATION;

ADIPOCYTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; PROSTAGLANDINS; TISSUE ENGINEERING;

EID: 35348823597     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0420     Document Type: Article

References (56)

1. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
2. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
3. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
4. Knippenberg, M., Helder, M.N., Zandieh Doulabi, B., Semeins, C.M., Wuisman, P.I., and Klein-Nulend, J. Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation. Tissue Eng 11, 1780, 2005.
5. Knippenberg, M., Helder, M.N., Zandieh Doulabi, B., Wuisman, P.I., and Klein-Nulend, J. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem Biophys Res Commun 342, 902, 2006.
6. Helder, M.N., Knippenberg, M., Klein-Nulend, J., and Wuisman, P.I. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng 13, 1799, 2007.
7. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
8. Rodriguez, L.V., Alfonso, Z., Zhang, R., Leung, J., Wu, B., and Ignarro, L.J. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 103, 12167, 2006.
9. Klein-Nulend, J., Burger, E.H., Semeins, C.M., Raisz, L.G., and Pilbeam, C.C. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J Bone Miner Res 12, 45, 1997.
10. Raisz, L.G., Pilbeam, C.C., and Fall, P.M. Prostaglandins: mechanisms of action and regulation of production in bone. Osteoporos Int 3 Suppl 1, 136, 1993.
11. Bakker, A.D., Soejima, K., Klein-Nulend, J., and Burger, E.H. The production of nitric oxide and prostaglandin E(2) by primary bone cells is shear stress dependent. J Biomech 34, 671, 2001.
12. Pilbeam, C.C., Harrison, J.R., and Raisz, L.G. Prostaglandins and bone metabolism. In: Bilezikian, J.P., Raisz, L.G., and Rodan, G.A., eds. Principles of Bone Biology. San Diego, CA: Academic Press, 2002, pp. 979-994.
13. Raisz, L.G., and Fall, P.M. Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 126, 1654, 1990.
14. Ono, K., Kaneko, H., Choudhary, S., Pilbeam, C.C., Lorenzo, J.A., Akatsu, T., Kugai, N., and Raisz, L.G. Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20, 23, 2005.
15. Blumenkrantz, N., and Sondergaard, J. Effect of prostaglandins E 1 and F 1 on biosynthesis of collagen. Nat New Biol 239, 246, 1972.
16. Raisz, L.G., and Koolemans-Beynen, A.R. Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture. Prostaglandins 8, 377, 1974.
17. Scutt, A., and Bertram, P. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10, 474, 1995.
18. Weinreb, M., Grosskopf, A., and Shir, N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol 276, E376, 1999.
19. Keila, S., Kelner, A., and Weinreb, M. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol 168, 131, 2001.
20. Smith, W.L., DeWitt, D.L., and Garavito, R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145, 2000.
21. Arikawa, T., Omura, K., and Morita, I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 200, 400, 2004.
22. Bakker, A.D., Klein-Nulend, J., and Burger, E.H. Mechanotransduction in bone cells proceeds via activation of COX-2, but not COX-1. Biochem Biophys Res Commun 305, 677, 2003.
23. Zhang, X., Schwarz, E.M., Young, D.A., Puzas, J.E., Rosier, R.N., and O'Keefe, R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109, 1405, 2002.
24. Clark, C.A., Schwarz, E.M., Zhang, X., Ziran, N.M., Drissi, H., O'Keefe, R.J., and Zuscik, M.J. Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun 328, 764, 2005.
25. Li, T.F., Zuscik, M.J., Ionescu, A.M., Zhang, X., Rosier, R.N., Schwarz, E.M., Drissi, H., and O'Keefe, R.J. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res 300, 159, 2004.
26. Vassaux, G., Gaillard, D., Darimont, C., Ailhaud, G., and Negrel, R. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 131, 2393, 1992.
27. Negrel, R., Gaillard, D., and Ailhaud, G. Prostacyclin as a potent effector of adipose-cell differentiation. Biochem J 257, 399, 1989.
28. Lee, K.S., Kim, H.J., Li, Q.L., Chi, X.Z., Ueta, C., Komori, T., Wozney, J.M., Kim, E.G., Choi, J.Y., Ryoo, H.M., and Bae, S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20, 8783, 2000.
29. Stein, G.S., Lian, J.B., van Wijnen, A.J., Stein, J.L., Montecino, M., Javed, A., Zaidi, S.K., Young, D.W., Choi, J.Y., and Pockwinse, S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23, 4315, 2004.
30. Gu, K., Zhang, L., Jin, T., and Rutherford, R.B. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells Tissues Organs 176, 28, 2004.
31. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
32. Klein-Nulend, J., Roelofsen, J., Semeins, C.M., Bronckers, A.L., and Burger, E.H. Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures. J Cell Physiol 170, 174, 1997.
33. Morinobu, M., Ishijima, M., Rittling, S.R., Tsuji, K., Yamamoto, H., Nifuji, A., Denhardt, D.T., and Noda, M. Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo. J Bone Miner Res 18, 1706, 2003.
34. Fall, P.M., Breault, D.T., and Raisz, L.G. Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line Py1a: structure-activity relations and signal transduction mechanisms. J Bone Miner Res 9, 1935, 1994.
35. Oedayrajsingh-Varma, M.J., van Ham, S.M., Knippenberg, M., Helder, M.N., Klein-Nulend, J., Schouten, T.E., Ritt, M.J., and van Milligen, F.J. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166, 2006.
36. Tjabringa, G.S., Vezeridis, P.S., Zandieh-Doulabi, B., Helder, M.N., Wuisman, P.I., and Klein-Nulend, J. Polyamines modulate nitric oxide production and COX-2 gene expression in response to mechanical loading in human adipose tissue-derived mesenchymal stem cells. Stem Cells 24, 2262, 2006.
37. Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W., and Gimble, J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189, 54, 2001.
38. Lowry, O.H. Micromethods for the assay of enzyme. II. Specific procedure. Alkaline phosphatase. Methods Enzymol 4, 371, 1957.
39. Raisz, L.G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 7, 419, 1999.
40. Raisz, L.G., Alander, C.B., Fall, P.M., and Simmons, H.A. Effects of prostaglandin F2 alpha on bone formation and resorption in cultured neonatal mouse calvariae: role of prostaglandin E2 production. Endocrinology 126, 1076, 1990.
41. Shamir, D., Keila, S., and Weinreb, M. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 34, 157, 2004.
42. Centrella, M., Casinghino, S., and McCarthy, T.L. Differential actions of prostaglandins in separate cell populations from fetal rat bone. Endocrinology 135, 1611, 1994.
43. Funk, C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871, 2001.
44. Zhan, P., Alander, C., Kaneko, H., Pilbeam, C.C., Guan, Y., Zhang, Y., Breyer, M.D., and Raisz, L.G. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes. Prostaglandins Other Lipid Mediat 78, 19, 2005.
45. Nemoto, K., Bernecker, P.M., Pilbeam, C.C., and Raisz, L.G. Expression and regulation of prostaglandin F receptor mRNA in rodent osteoblastic cells. Prostaglandins 50, 349, 1995.
46. Liu, L., and Clipstone, N.A. Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. J Cell Biochem 100, 161, 2007.
47. Casimir, D.A., Miller, C.W., and Ntambi, J.M. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation 60, 203, 1996.
48. Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., Yamaguchi, K., Segi, E., Tsuboyama, T., Matsushita, M., Ito, K., Ito, Y., Sugimoto, Y., Ushikubi, F., Ohuchida, S., Kondo, K., Nakamura, T., and Narumiya, S. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 99, 4580, 2002.
49. Wan, M., and Cao, X. BMP signaling in skeletal development. Biochem Biophys Res Commun 328, 651, 2005.
50. Chikazu, D., Li, X., Kawaguchi, H., Sakuma, Y., Voznesensky, O.S., Adams, D.J., Xu, M., Hoshio, K., Katavic, V., Herschman, H.R., Raisz, L.G., and Pilbeam, C.C. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17, 1430, 2002.
51. Vaes, B.L., Ducy, P., Sijbers, A.M., Hendriks, J.M., van Someren, E.P., de Jong, N.G., van den Heuvel, E.R., Olijve, W., van Zoelen, E.J., and Dechering, K.J. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone 39, 724, 2006.
52. Miller, C.W., Casimir, D.A., and Ntambi, J.M. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha. Endocrinology 137, 5641, 1996.
53. Weinreb, M., Suponitzky, I., and Keila, S. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone 20, 521, 1997.
54. Sasaoka, R., Terai, H., Toyoda, H., Imai, Y., Sugama, R., and Takaoka, K. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 318, 704, 2004.
55. Toyoda, H., Terai, H., Sasaoka, R., Oda, K., and Takaoka, K. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 37, 555, 2005.
56. Olschewski, H., Rose, F., Grunig, E., Ghofrani, H.A., Walmrath, D., Schulz, R., Schermuly, R., Grimminger, F., and Seeger, W. Cellular pathophysiology and therapy of pulmonary hypertension. J Lab Clin Med 138, 367, 2001.